← Evidence map

ArticleEJHaem2022

New Indications and platforms for CAR-T therapy in lymphomas beyond DLBCL.

Madiha Iqbal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2022
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 34988550